Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights
Provided By GlobeNewswire
Last update: May 15, 2025
First Patient Enrolled in Multi-Dose Phase 1b/2 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer (NMIBC); Initial Data at 3 Months Expected by Year-End 2025
Read more at globenewswire.com
